Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04285671 |
|---|---|
| Brief Title: | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer |
| First Submitted : | February 25, 2020 |
| First Submitted that Met QC Criteria : | February 25, 2020 |
| First Posted : | February 26, 2020 |
| Last Update Submitted that Met QC Criteria : | January 5, 2023 |
| Last Update Posted : | January 6, 2023 |